BNP Paribas Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1M Buy
59,926
+34,454
+135% +$577K ﹤0.01% 755
2025
Q1
$391K Buy
+25,472
New +$391K ﹤0.01% 821
2021
Q2
Sell
-13,572
Closed -$157K 933
2021
Q1
$157K Sell
13,572
-3,991
-23% -$46.2K ﹤0.01% 836
2020
Q4
$169K Sell
17,563
-11,694
-40% -$113K ﹤0.01% 835
2020
Q3
$264K Buy
29,257
+17,132
+141% +$155K ﹤0.01% 790
2020
Q2
$150K Buy
+12,125
New +$150K ﹤0.01% 798
2019
Q2
Sell
-28,168
Closed -$442K 952
2019
Q1
$442K Sell
28,168
-5,404
-16% -$84.8K ﹤0.01% 811
2018
Q4
$527K Sell
33,572
-16,220
-33% -$255K ﹤0.01% 795
2018
Q3
$1.07M Hold
49,792
0.01% 698
2018
Q2
$1.22M Sell
49,792
-75,520
-60% -$1.85M 0.01% 705
2018
Q1
$2.14M Buy
+125,312
New +$2.14M 0.02% 626
2016
Q4
Sell
-25,521
Closed -$1.17M 1065
2016
Q3
$1.17M Sell
25,521
-541
-2% -$24.9K 0.01% 810
2016
Q2
$1.31M Hold
26,062
0.01% 767
2016
Q1
$1.4M Sell
26,062
-62,337
-71% -$3.34M 0.01% 752
2015
Q4
$5.8M Sell
88,399
-1,842
-2% -$121K 0.05% 423
2015
Q3
$5.1M Buy
90,241
+13,010
+17% +$735K 0.04% 463
2015
Q2
$4.56M Buy
77,231
+10,672
+16% +$631K 0.04% 519
2015
Q1
$4.15M Buy
66,559
+22,445
+51% +$1.4M 0.03% 545
2014
Q4
$2.54M Sell
44,114
-1,813
-4% -$104K 0.02% 569
2014
Q3
$2.47M Sell
45,927
-4,984
-10% -$268K 0.02% 582
2014
Q2
$2.67M Sell
50,911
-83,972
-62% -$4.4M 0.02% 588
2014
Q1
$7.13M Buy
134,883
+99,997
+287% +$5.28M 0.05% 353
2013
Q4
$1.4M Sell
34,886
-1,169
-3% -$46.8K 0.01% 689
2013
Q3
$1.36M Sell
36,055
-32,366
-47% -$1.22M 0.01% 666
2013
Q2
$2.68M Buy
+68,421
New +$2.68M 0.02% 557